CJC-1295 NO DAC — 2 mg

CJC-1295 NO DAC — 2 mg

CJC-1295 NO DAC is a synthetic peptide widely studied in research settings for its selective interaction with growth hormone–releasing hormone (GHRH) pathways without long-acting modifications. Researchers examine it for how it stimulates pulsatile growth hormone signaling, aligns with natural circadian secretion patterns, and influences downstream physiological markers without broadly activating other pituitary hormone systems.

Key Research Observations on CJC-1295 NO DAC

Pulsatile growth hormone release
Research literature describes CJC-1295 NO DAC as a short-acting GHRH analog that stimulates growth hormone release in a pulse-like manner, closely resembling endogenous growth hormone secretion dynamics.

Minimal impact on non–growth hormone pituitary hormones
Studies note that CJC-1295 NO DAC demonstrates specificity for growth hormone pathways, with little to no observed elevation in cortisol, prolactin, or other pituitary hormones in research models.

Alignment with circadian growth hormone rhythms
Scientific investigation explores how CJC-1295 NO DAC may synchronize with natural growth hormone pulse timing, particularly during sleep-associated secretion windows.

Interest in recovery and metabolic signaling research
Academic and preclinical research examines CJC-1295 NO DAC for its downstream effects on protein synthesis signaling, tissue recovery markers, and metabolic regulation pathways under controlled experimental conditions.